Accessibility settings

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/80263, first published .
Healthcare worker scans senior man's forehead with thermometer in clinic.

COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study

COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study

Jacqueline K Kueper   1 , PhD ;   Kalyani Kottilil   1 , BSc ;   Giorgio Quer   1 , PhD ;   Danielle C Chiang   1 , MPH ;   Emily G Spencer   1 , PhD ;   Jyothi Purushotham   1, 2 , PhD ;   Edward Ramos   1, 3 , PhD ;   Leila Roumani   4 , DMD, MPH ;   Kristian G Andersen   1, 2 , PhD ;   Eric J Topol   1 , MD ;   Jay A Pandit   1 * , MD ;   Michael J Mina   4, 5 * , MD, PhD

1 Scripps Research Translational Institute, Scripps Research Institute, La Jolla, CA, United States

2 Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA, United States

3 Care Evolution, Ann Arbor, MI, United States

4 eMed, Miami, FL, United States

5 Immune Observatory, Boston, MA, United States

*these authors contributed equally

Corresponding Author:

  • Jacqueline K Kueper, PhD
  • Scripps Research Translational Institute
  • Scripps Research Institute
  • 10550 North Torrey Pines Road
  • La Jolla, CA 92037
  • United States
  • Phone: 1 858-784-1000
  • Email: jakykueper@gmail.com